KMT2D is mutated in about 30% of DLBCL and is one of the most frequent mutations in DLBCL (most are frameshift or nonsense mutations) (Morin et al., 2011; Schmitz et al., 2018). The gene discussed is KMT2D; the disease is diffuse large B-cell lymphoma.